cdmo.directory
← Compare landing

LGM Pharma vs Parimer Scientific

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryLGM PharmaParimer Scientific
SummaryLGM Pharma offers full-service CDMO support from concept through commercialization, plus API sourcing. It provides analytical method development and stability testing for APIs and drug products, with regulatory strategy support for 505(b)(2) and ANDA filings.U.S.-based CDMO offering chemical process development, analytical method development, and small-to-mid-scale GMP drug substance manufacturing. Founded in 2018, it serves startups, university researchers, and mid-size companies.
Services
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • CMC Regulatory Submission Support
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • CMC Regulatory Submission Support
Modalities
  • Small Molecule
  • Small Molecule
Development capabilities
  • Analytical method development
  • Analytical method development
  • Formulation development
  • ICH stability testing
Manufacturing capabilitiesData not yet provided.
  • Drug Substance (DS)
  • Max chemical: Pilot (10 kg – 100 kg)
  • DEA licensed
LocationsData not yet provided.
  • U.S. GMP facility, United States
CertificationsData not yet provided.Data not yet provided.

Find similar companies

LGM Pharma alternatives · Parimer Scientific alternatives

Markdown mirror: /compare/lgmpharma/parimer.md